APA (7th ed.) Citation

JA, M., J, A., JE, R., D, B., M, A., ME, G., . . . C, K. (2025). Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma. Clinical lung cancer, 26(3), 165. https://doi.org/10.1016/j.cllc.2024.12.001

Chicago Style (17th ed.) Citation

JA, Marks, et al. "Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma." Clinical Lung Cancer 26, no. 3 (2025): 165. https://doi.org/10.1016/j.cllc.2024.12.001.

MLA (9th ed.) Citation

JA, Marks, et al. "Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma." Clinical Lung Cancer, vol. 26, no. 3, 2025, p. 165, https://doi.org/10.1016/j.cllc.2024.12.001.